BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2407347)

  • 1. Rapid degradation of extracellular matrix proteins by normal human uroepithelial cells.
    Allen LE; Dubeau L; Alvarez O; Jones PA
    Cancer Res; 1990 Mar; 50(6):1897-904. PubMed ID: 2407347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
    Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
    Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins.
    Rutka JT; Giblin JR; Apodaca G; DeArmond SJ; Stern R; Rosenblum ML
    Cancer Res; 1987 Jul; 47(13):3515-22. PubMed ID: 3555773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of plasminogen in matrix breakdown by neoplastic cells.
    Bogenmann E; Jones PA
    J Natl Cancer Inst; 1983 Dec; 71(6):1177-82. PubMed ID: 6581358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium.
    Dubeau L; Jones PA; Rideout WM; Laug WE
    Cancer Res; 1988 Oct; 48(19):5552-6. PubMed ID: 3138024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line.
    Boyd D; Brattain M
    Cancer Res; 1989 Apr; 49(8):1948-53. PubMed ID: 2539250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells degrade extracellular matrix proteins produced in vitro.
    Laug WE; Weinblatt ME; Jones PA
    Thromb Haemost; 1985 Aug; 54(2):498-502. PubMed ID: 4082085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New experimental models for the in vitro reconstitution of human bladder mucosa.
    De Angeli S; Del Pup L; Fandella A; Di Liddo R; Anselmo G; Macchi C; Conconi MT; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2004 Sep; 14(3):367-72. PubMed ID: 15289887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
    Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
    Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM; Waghray A
    Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
    Niedbala MJ; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells.
    Jones PA; DeClerck YA
    Cancer Res; 1980 Sep; 40(9):3222-7. PubMed ID: 7000340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free medium for the in vitro growth of normal and malignant urinary bladder epithelial cells.
    Messing EM; Fahey JL; deKernion JB; Bhuta SM; Bubbers JE
    Cancer Res; 1982 Jun; 42(6):2392-7. PubMed ID: 7074617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium.
    Dubeau L; Jones PA
    Cancer Res; 1987 Apr; 47(8):2107-12. PubMed ID: 3493840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
    Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
    Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosaminoglycan production in cultures of early and late passage human endothelial cells: the influence of an anionic endothelial cell growth factor and the extracellular matrix.
    Gordon PB; Conn G; Hatcher VB
    J Cell Physiol; 1985 Dec; 125(3):596-607. PubMed ID: 3905832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix.
    Morton DM; Barrack ER
    Cancer Res; 1995 Jun; 55(12):2596-602. PubMed ID: 7780974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by bovine endothelial cells of degradation by HT-1080 fibrosarcoma cells of extracellular matrix proteins.
    Heisel M; Laug WE; Jones PA
    J Natl Cancer Inst; 1983 Dec; 71(6):1183-7. PubMed ID: 6418940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of extracellular-matrix synthesized by cultured stromal cells from normal human breast tissue by epidermal growth factor.
    Baley P; Lützelschwab I; Scott-Burden T; Küng W; Eppenberger U
    J Cell Biochem; 1990 Jun; 43(2):111-25. PubMed ID: 2380258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant cyclic adenosine 3':5'-monophosphate metabolism in cultures of tumorigenic rat urothelium.
    Chlapowski FJ; Nemecek GM
    Cancer Res; 1985 Jan; 45(1):122-7. PubMed ID: 2981157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.